Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
du Bois A, Kristensen G, Ray-Coquard I, Reuss A, Pignata S, Colombo N, Denison U, Vergote I, Del Campo JM, Ottevanger P, Heubner M, Minarik T, Sevin E, de Gregorio N, Bidziński M, Pfisterer J, Malander S, Hilpert F, Mirza MR, Scambia G, Meier W, Nicoletto MO, Bjørge L, Lortholary A, Sailer MO, Merger M, Harter P; AGO Study Group led Gynecologic Cancer Intergroup/European Network of Gynaecologic Oncology Trials Groups Intergroup Consortium. du Bois A, et al. Among authors: nicoletto mo. Lancet Oncol. 2016 Jan;17(1):78-89. doi: 10.1016/S1470-2045(15)00366-6. Epub 2015 Nov 16. Lancet Oncol. 2016. PMID: 26590673 Free article. Clinical Trial.
Experience with intraperitoneal alpha-2a interferon.
Nicoletto MO, Fiorentino MV, Vinante O, Prosperi A, Tredese F, Tumolo S, Cima GP, Monfardini S. Nicoletto MO, et al. Oncology. 1992;49(6):467-73. doi: 10.1159/000227094. Oncology. 1992. PMID: 1465286
Surgical second look in ovarian cancer: a randomized study in patients with laparoscopic complete remission--a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group Study.
Nicoletto MO, Tumolo S, Talamini R, Salvagno L, Franceschi S, Visonà E, Marin G, Angelini F, Brigato G, Scarabelli C, Carbone A, Cecchetto A, Prosperi A, Rosabian A, Giusto M, Cima GP, Morassut S, Nascimben O, Vinante O, Fiorentino MV. Nicoletto MO, et al. J Clin Oncol. 1997 Mar;15(3):994-9. doi: 10.1200/JCO.1997.15.3.994. J Clin Oncol. 1997. PMID: 9060538 Clinical Trial.
Elderly ovarian cancer: treatment with mitoxantrone-carboplatin.
Nicoletto MO, Artioli G, Donach M, Sileni VC, Monfardini S, Talamini R, Veronesi A, Ferrazzi E, Tumolo S, Visonà E, Amichetti M, Endrizzi L, Salvagno L, Prosperi A, Azzoni P. Nicoletto MO, et al. Gynecol Oncol. 2001 Feb;80(2):221-6. doi: 10.1006/gyno.2000.6017. Gynecol Oncol. 2001. PMID: 11161863 Clinical Trial.
Long-term survival in a randomized study of nonplatinum therapy versus platinum in advanced epithelial ovarian cancer.
Nicoletto MO, Tumolo S, Sorio R, Cima G, Endrizzi L, Nascimben O, Vinante O, Artioli G, Donach M, Cartei G; Goccne Group (Gruppo Oncologico Cooperativo Clinico Nord-est), Padua, Italy. Nicoletto MO, et al. Int J Gynecol Cancer. 2007 Sep-Oct;17(5):986-92. doi: 10.1111/j.1525-1438.2007.00862.x. Epub 2007 Feb 19. Int J Gynecol Cancer. 2007. PMID: 17316364 Clinical Trial.
Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer.
Lhommé C, Joly F, Walker JL, Lissoni AA, Nicoletto MO, Manikhas GM, Baekelandt MM, Gordon AN, Fracasso PM, Mietlowski WL, Jones GJ, Dugan MH. Lhommé C, et al. Among authors: nicoletto mo. J Clin Oncol. 2008 Jun 1;26(16):2674-82. doi: 10.1200/JCO.2007.14.9807. J Clin Oncol. 2008. PMID: 18509179 Clinical Trial.
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial.
Daniele G, Lorusso D, Scambia G, Cecere SC, Nicoletto MO, Breda E, Colombo N, Artioli G, Cannella L, Lo Re G, Raspagliesi F, Maltese G, Salutari V, Ferrandina G, Greggi S, Baldoni A, Bergamini A, Piccirillo MC, Tognon G, Floriani I, Signoriello S, Perrone F, Pignata S. Daniele G, et al. Among authors: nicoletto mo. Gynecol Oncol. 2017 Feb;144(2):256-259. doi: 10.1016/j.ygyno.2016.12.011. Epub 2016 Dec 16. Gynecol Oncol. 2017. PMID: 27993479 Clinical Trial.
52 results